On the contrary, recipients who developed BOS showed a decline in CD4+ and an increase in CD8+ cells, with a significant decline in the CD4:CD8 ratio in the same matrix in the same period. The gene discussed is CD4; the disease is Buschke-Ollendorff syndrome.